1. Association between progesterone treatment and neonatal outcome in preterm births: a retrospective analysis
- Author
-
Shir Danieli-Gruber, Gal Greenberg, Shirley Shechter, Asaf Romano, Anat Shmueli, Shiri Barbash-Hazan, Ron Bardin, Eyal Krispin, and Eran Hadar
- Subjects
Administration, Intravaginal ,Pregnancy ,Infant, Newborn ,Infant ,Humans ,Premature Birth ,Birth Weight ,Obstetrics and Gynecology ,Female ,Progestins ,Progesterone ,Infant, Premature ,Retrospective Studies - Abstract
This retrospective study was conducted to determine if infants born prematurely despite prophylactic maternal progesterone treatment during pregnancy may still benefit from its adjunct properties and have decreased neonatal complications. 248 women treated with vaginal/intramuscular progesterone during pregnancy and 2519 controls who gave birth to a preterm newborn (24 + 0-36 + 6 gestational weeks) at a tertiary medical centre in 2012-2019. The primary outcome measure was neonatal infectious composite outcome. Secondary outcome measures were other maternal and neonatal complications. Compared to controls, the study group was characterised by lower gestational age at birth (35.0 ± 2.66 vs. 36.0 ± 2.23 weeks
- Published
- 2022
- Full Text
- View/download PDF